Skip to main content
. 2022 Aug 3;10(8):1244. doi: 10.3390/vaccines10081244

Table 3.

Comparison between “anti SARS-CoV-2 antibody titer”, expressed in UA/mL and several symptoms among the SARS-CoV-2 positive individuals.

Factor Median (IQR) p-Value
Symptoms 0.047
No 591.5 (413.6–769.4)
Yes 5415.6 (2410.0–10,232.0)
Hospitalization 0.254
No 2846.9 (1405.2–8207.5)
Yes 8122.6 (5405.7–31,526.0)
Dyspnoea 0.536
No 2846.9 (1405.2–8207.5)
Yes 5415.6 (2625.1–26,463.8)
Fever > 38 °C 0.604
No 2658.0 (680.4–13,862.7)
Yes 5415.6 (2224.3–7729.9)
Pneumonia 0.109
No 2846.9 (1405.3–7785.6)
Yes 26,463.8 (14,576.3–40,696.6)
Headache 0.701
No 2688.9 (1028.2–14,398.3)
Yes 4450.3 (2458.1–8025.9)
Ageusia/Anosmia 1.000
No 2690.9 (1482.1–14,398.3)
Yes 5656.6 (1641.6–8025.9)
Cough 0.592
No 2690.9 (769.4–8685.2)
Yes 4209.3 (2302.4–17,114.2)